<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03874364</url>
  </required_header>
  <id_info>
    <org_study_id>Lidocaine-study</org_study_id>
    <nct_id>NCT03874364</nct_id>
  </id_info>
  <brief_title>The Effect of Intraurethral Lidocaine Gel on Pain Perception During Flexible Cystoscopy</brief_title>
  <official_title>The Effect of Intraurethral Lidocaine Gel in Comparison With Plain Lubricating Gel on Pain Perception During Flexible Cystoscopy: A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajet Hyseni</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Luzerner Kantonsspital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Flexible cystoscopy is routinely performed by urologists. Many patients have concerns to
      undergo this procedure and expect it to be unpleasant or even painful. Thus, reduction of
      pain and discomfort during cystoscopy is of great interest, but there is not sufficient
      evidence regarding the most appropriate conduct of cystoscopy.

      In this study the impact of lidocaine gel, patient counseling and monitoring regarding pain
      perception during flexible cystoscopy are investigated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain based on a numeric rating scale</measure>
    <time_frame>During flexible cystoscopy</time_frame>
    <description>The pain scale ranging from 0 (&quot;no pain&quot;) to 10 (&quot;worst possible pain&quot;).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain based on a numeric rating scale</measure>
    <time_frame>Immediately before flexible cystoscopy</time_frame>
    <description>The pain scale ranging from 0 (&quot;no pain&quot;) to 10 (&quot;worst possible pain&quot;).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain based on a numeric rating scale</measure>
    <time_frame>10 min after flexible cystoscopy</time_frame>
    <description>The pain scale ranging from 0 (&quot;no pain&quot;) to 10 (&quot;worst possible pain&quot;).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain based on a numeric rating scale</measure>
    <time_frame>3 days after flexible cystoscopy</time_frame>
    <description>The pain scale ranging from 0 (&quot;no pain&quot;) to 10 (&quot;worst possible pain&quot;).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain based on a verbal rating scale</measure>
    <time_frame>Immediately after flexible cystoscopy</time_frame>
    <description>The pain scale ranging from 0 (&quot;it was not unpleasant&quot;) to 5 (&quot;the investigation was almost unbearable&quot;).</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Flexible Cystoscopy</condition>
  <arm_group>
    <arm_group_label>Lidocaine gel, counselling, monitor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine gel, counselling, no monitor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine gel, no counselling, monitor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine gel, no counselling, no monitor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lubricating gel, counselling, monitor</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lubricating gel, counselling, no monitor</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lubricating gel, no counselling, monitor</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Lubricating gel, no counselling, no monitor</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lidocaine gel</intervention_name>
    <description>10 ml 2% lidocaine gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.</description>
    <arm_group_label>Lidocaine gel, counselling, monitor</arm_group_label>
    <arm_group_label>Lidocaine gel, counselling, no monitor</arm_group_label>
    <arm_group_label>Lidocaine gel, no counselling, monitor</arm_group_label>
    <arm_group_label>Lidocaine gel, no counselling, no monitor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Counselling</intervention_name>
    <description>Patients receive a brochure in the waiting room explaining the procedure in details.</description>
    <arm_group_label>Lidocaine gel, counselling, monitor</arm_group_label>
    <arm_group_label>Lidocaine gel, counselling, no monitor</arm_group_label>
    <arm_group_label>Lubricating gel, counselling, monitor</arm_group_label>
    <arm_group_label>Lubricating gel, counselling, no monitor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Monitor</intervention_name>
    <description>Patients are allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.</description>
    <arm_group_label>Lidocaine gel, counselling, monitor</arm_group_label>
    <arm_group_label>Lidocaine gel, no counselling, monitor</arm_group_label>
    <arm_group_label>Lubricating gel, counselling, monitor</arm_group_label>
    <arm_group_label>Lubricating gel, no counselling, monitor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lubricating gel</intervention_name>
    <description>10 ml plain lubrificant gel is instilled with a syringe through the length of the urethra and kept in site at least 5 minutes prior the introduction of the cystoscope.</description>
    <arm_group_label>Lubricating gel, counselling, monitor</arm_group_label>
    <arm_group_label>Lubricating gel, counselling, no monitor</arm_group_label>
    <arm_group_label>Lubricating gel, no counselling, monitor</arm_group_label>
    <arm_group_label>Lubricating gel, no counselling, no monitor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No counselling</intervention_name>
    <description>Patients won't receive a brochure in the waiting room explaining the procedure in details.</description>
    <arm_group_label>Lidocaine gel, no counselling, monitor</arm_group_label>
    <arm_group_label>Lidocaine gel, no counselling, no monitor</arm_group_label>
    <arm_group_label>Lubricating gel, no counselling, monitor</arm_group_label>
    <arm_group_label>Lubricating gel, no counselling, no monitor</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No monitor</intervention_name>
    <description>Patients are not allowed to view and follow the procedure on a monitor connected to the cystoscope's camera.</description>
    <arm_group_label>Lidocaine gel, counselling, no monitor</arm_group_label>
    <arm_group_label>Lidocaine gel, no counselling, no monitor</arm_group_label>
    <arm_group_label>Lubricating gel, counselling, no monitor</arm_group_label>
    <arm_group_label>Lubricating gel, no counselling, no monitor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men 18 — 80 years

          -  Given indication for flexible cystoscopy

          -  Written informed consent

        Exclusion Criteria:

          -  Allergy to amid anesthetics

          -  Urinary tract infection

          -  Use of analgesics in the previous 24 hours and chronic intake of analgesics

          -  Dementia

          -  Presence of a sensory disorder such as or spinal cord injury

          -  Indwelling catheter carrier
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ajet Hyseni, Dr.med.univ.RKS</last_name>
    <phone>0+41 41 205 6959</phone>
    <email>ajet.hyseni@luks.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carlo Di Bona</last_name>
    <phone>+41 41 205 6308</phone>
    <email>carlo.dibona@luks.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Klinik für Urologie, Kantonsspital Luzern</name>
      <address>
        <city>Lucerne</city>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlo Di Bona</last_name>
      <phone>+41 41 205 6308</phone>
      <email>carlo.dibona@luks.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 12, 2019</study_first_submitted>
  <study_first_submitted_qc>March 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2019</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Luzerner Kantonsspital</investigator_affiliation>
    <investigator_full_name>Ajet Hyseni</investigator_full_name>
    <investigator_title>Dr.med.univ.RKS</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

